The association between the fluoxetine use and the occurrence of coronary heart disease: a nationwide retrospective cohort study
Abstract Background We explored if the administration of fluoxetine, recognized for its potential in adipocyte browning, entails a differential risk of coronary heart disease (CHD) in comparison to other SSRI medications. Methods Using the National Health Insurance Research Database of Taiwan from 2...
Saved in:
| Main Authors: | Fang-Ling Li, Yu-Tse Sheih, Ming-Hsun Lin, Yong-Chen Chen, Wen-Tung Wu, Tsung-Kun Lin, Yu‐Ching Chou, Chien‐An Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-024-04280-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suicide-related risk among patients using branded and generic fluoxetine: a propensity score-matched, new‐user design in Taiwan
by: Cong-Wei Zheng, et al.
Published: (2024-11-01) -
Fluoxetine inhibited RANKL-induced osteoclastic differentiation in vitro
by: Zhang Jing-wen, et al.
Published: (2024-12-01) -
Fluoxetine, but not paroxetine, alters the jaw-closing muscle activity during non-rapid eye movement sleep in mice
by: Minako Ikeda, et al.
Published: (2025-01-01) -
Chirality in Modern Antidepressants: A Comprehensive Review of Stereochemical Impacts on Pharmacology and Therapeutics
by: Gabriel Hancu, et al.
Published: (2024-09-01) -
Unveiling the efficacy of paroxetine and gabapentin in ulcerative colitis patients in remission with co-existing IBS-like symptoms: a single-blinded randomized clinical trial
by: Farahnaz Safaei, et al.
Published: (2024-11-01)